Drug utilization evaluation of imipenem/cilastatin in patients with renal dysfunction.
Sheakely
M L
ML
Nicolau
D P
DP
Agner
S I
SI
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015377:Cilastatin / Q000008:administration & dosage / Q000009:adverse effects*; D000077728:Cilastatin, Imipenem Drug Combination; D004338:Drug Combinations; D004363:Drug Utilization; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage / Q000009:adverse effects*; D007674:Kidney Diseases / Q000150:complications*; D012640:Seizures / Q000150:complications
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination